# Estimating population structure using epigenome-wide methylation data

**Authors:** Ziqing Wang, Kent D Taylor, Jerome I Rotter, Stephen S Rich, Yinan Zheng, Lifang Hou, Xiuqing Guo, Jan Bressler, Laura M Raffield, Yongmei Liu, Robert Kaplan, Donald M Lloyd-Jones, Alanna C Morrison, Myriam Fornage, Bruce M Psaty, Jennifer A Brody, Tamar Sofer

PMC · DOI: 10.1093/bib/bbag142 · 2026-03-28

## TL;DR

This paper introduces a new method to estimate population structure using DNA methylation data, which can help improve the accuracy of epigenome-wide association studies.

## Contribution

The novel contribution is the development of methylation population scores (MPSs) to predict genetic principal components using supervised learning.

## Key findings

- MPSs showed strong correlation with genetic principal components (GPCs), with R² ranging from 0.27 to 0.98.
- MPSs outperformed alternative methylation-based methods in differentiating self-reported racial/ethnic groups.
- MPSs reduced inflation in EWAS similarly to GPCs and can be used when genetic data are unavailable.

## Abstract

Population stratification is one of the source of inflation in epigenome-wide association studies (EWAS) when not properly accounted for. To address this, we developed methylation population scores (MPSs) to predict genetic principal components (GPCs) using a feature selection approach. We used multi-ethnic DNA methylation data from Illumina EPIC arrays across five cohorts, including MESA (n = 929), CARDIA (n = 1123), JHS (n = 1365), ARIC (n = 2338), and HCHS/SOL (n = 1475), randomly splitting participants into training (85%) and test (15%) sets. Within each cohort, associations between GPCs and CpG sites were estimated using linear regression adjusting for age, sex, smoking and alcohol use, race/ethnicity, body mass index, and cell type proportions, followed by meta-analysis and selection of CpGs with FDR <0.05. We then applied a two-stage weighted least squares Lasso regression to construct MPSs, adjusting for the aforementioned covariates. In the test dataset, MPSs showed strong correlation with GPCs, with R² ranging from 0.27 (MPS7 vs. GPC7) to 0.98 (MPS1 vs. GPC1). Visualization demonstrated that MPSs recapitulated the pattern shown by GPCs in differentiating self-reported White, Black, and Hispanic/Latino groups and outperformed methylation-based principal components constructed using alternative published methods. Additionally, MPSs showed comparable performance to GPCs in reducing inflation in EWAS. Overall, MPSs uses supervised learning with covariate adjustment to capture genetic structure across diverse populations, and provide a reliable estimate of population structure in the data and can complement GPCs when genetic data are absent.

## Full-text entities

- **Genes:** TTK (TTK protein kinase) [NCBI Gene 7272] {aka CT96, ESK, MPH1, MPS1, MPS1L1, PYT}, LYST (lysosomal trafficking regulator) [NCBI Gene 1130] {aka CHS, CHS1, Mauve}, GYPC (glycophorin C (Gerbich blood group)) [NCBI Gene 2995] {aka CD236, CD236R, GE, GPC, GPD, GYPD}, GPC4 (glypican 4) [NCBI Gene 2239] {aka K-glypican, KPTS}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, GPC3 (glypican 3) [NCBI Gene 2719] {aka DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB}, GPC2 (glypican 2) [NCBI Gene 221914], IDS (iduronate 2-sulfatase) [NCBI Gene 3423] {aka ID2S, MPS2, SIDS}, GPC1 (glypican 1) [NCBI Gene 2817] {aka glypican}, GPC5 (glypican 5) [NCBI Gene 2262]
- **Diseases:** MPSs (MESH:C535434), CARDIA (MESH:C563569), Diabetes (MESH:D003920), ARIC (MESH:D050197), Coronary Artery (MESH:D003324), CARDIA (MESH:D004938), heart, lung, blood, and sleep disorders (MESH:D006331), MPS (MESH:D009084), type 2 diabetes (MESH:D003924), GPCs (MESH:C566443)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13032028/full.md

---
Source: https://tomesphere.com/paper/PMC13032028